LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding – Focused Commentary

Presenter: Martin W Bergmann

REGISTER for free or LOG IN to view this content

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding – Focused Commentary

We Recommend